DFTX:NASDAQ
Definium Therapeutics Inc
$35.67
arrow_downward
-0.92%(-0.33) 1D
$35.67
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 23, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DFTX...
Open
$36.01
High
$36.12
Low
$35.09
Mkt. cap
4.79B
Avg. vol.
2.43M
Volume
1.75M
52-wk high
$49.70
52-wk low
$14.62
EPS
-$3.43
Beta
2.19
Shares outstanding
134.37M
No. of employees
106
Open
$36.01
High
$36.12
Low
$35.09
Mkt. cap
4.79B
Avg. vol.
2.43M
Volume
1.75M
52-wk high
$49.70
52-wk low
$14.62
EPS
-$3.43
Beta
2.19
Shares outstanding
134.37M
No. of employees
106
News stories
From web sources and news partners
Seeking Alpha
·
18 minutes ago
The S&P 500 Is At A Crossroads, That's A Buying Opportunity (SP500)
Cryptonews.net
·
1 hour ago
This S&P 500 crash signal just made a major positive U-turn
Bloomberg.com
·
6 hours ago
Zero-Day Option Traders Are Betting Against Big S&P 500 Swings
Yahoo Finance
·
4 hours ago
Dow: 3 Key Takeaways for Long-Term Investors
Profile
Definium Therapeutics, Inc., formerly known as MindMed, is a New York-based biotechnology company that is currently developing clinical and therapeutic applications for psychedelic and, more broadly, psychoplastogenic drugs. Wikipedia
About Definium Therapeutics Inc
CEORobert Barrow
Employees106
Founded2010
Headquarters-
SectorPharmaceutical industry
Websitedefiniumtx.com